“…The determination of cytokines in the serum of tumor-bearing nude mice can reflect the antitumor mechanism of various tripterine treatments. It is well known that IFN-γ, IL-2, and IL-12A are capable of inhibiting tumor cell proliferation, blocking the angiogenesis pathway, regulating immunity, and decreasing the formation of tumor-associated fibroblasts (TAFs) (Mumm et al., 2011 ; Bunimovich-Mendrazitsky et al., 2016 ; Komohara et al., 2016 ; Yue et al., 2016 ; Jiang et al., 2017 ; Vourc’h et al., 2017 ; Wu et al., 2017 ; Ayuthaya et al., 2018 ; Burkart et al., 2018 ; Hydes et al., 2018 ; Kamensek et al., 2018 ; Lampreht Tratar et al., 2018 ; Posadassánchez & Vargasalarcón, 2018 ). In contrast, IL-10, IL-6, CCl2, TNF-α, and TGF-β are considered to be tumor-promoting cytokines, which could promote the proliferation of tumor cells, rebuilding of vascular networks, and so on (Alhamarneh et al., 2015 ; Song et al., 2015 ; Lau et al., 2016 ; Suchal et al., 2016 ; Kim et al., 2017 ; Kong et al., 2017 ).…”